Pathways for Small Patient Populations with Andre Bessette

https://is1-ssl.mzstatic.com/image/thumb/PodcastSource211/v4/33/d2/45/33d24523-af79-8f08-bbfc-fe77064493ac/1aa65594-2f7d-4ecb-ac99-ffa0e11326df.png/600x600bb.jpg

Impact1 Voices

Impact1 at Stanford Biodesign

9 episodes

4 days ago

Impact1 works to accelerate pediatric and maternal health technology to improve children’s lives from day one. In this podcast, co-hosts Janene Fuerch and Juliana Perl speak with leaders in healthcare innovation from around the globe to share insights on their challenges and successes in delivering new solutions. Impact1 is based at Stanford University’s Mussallem Center for Biodesign. Disclaimer of Endorsement: All references to specific products, companies, or services are for educational purposes only and do not constitute or imply an endorsement by Stanford University or Biodesign.

Medicine

Health & Fitness

RSS

All content for Impact1 Voices is the property of Impact1 at Stanford Biodesign and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42134477/42134477-1727807292622-93548f2d0d1ba.jpg

Pathways for Small Patient Populations with Andre Bessette

Impact1 Voices

28 minutes 53 seconds

6 months ago

Pathways for Small Patient Populations with Andre Bessette

Andre Bessette is the CEO of Eclipse Regenesis, a company developing a mechanical solution to short bowel syndrome. In this episode, Andre highlights the regulatory pathways available to solutions addressing needs in small patient populations. He also discusses clinical study site selection, payor engagement, and the current challenges of short bowel syndrome and necrotizing enterocolitis care.